Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Sequent Medical (Aliso Viejo, CA) a development-stage medical device company focused on endovascular treatment of neurovascular disease conditions, closed a $15.6M Series B financing. Participants include Domain Associates, Versant Ventures and US Venture Partners.

Achaogen (San Francisco, CA) a clinical-stage a biopharmaceutical company focused on the discovery and development of broad-spectrum antibiotics to treat life-threatening, multi-drug resistant bacterial infections, closed a $56M Series C financing. Participants include Frazier Healthcare Ventures, Alta Partners, 5 AM Ventures, ARCH Venture Partners, Domain Associates, Venrock Associates, Versant Ventures and Wellcome Trust.

Flexion Therapeutics (Woburn, MA) a clinical-stage biopharma focused on autoimmune disease, ulcerative colitis and tinnitus, closed a $9M Series A financing, bringing the total round to $42M. Participants include Pfizer Venture Investments, Versant Ventures, 5AM Ventures and Sofinnova Ventures.

Intuity Medical (Sunnyvale, CA) a clinical-stage diagnostic device company focused on all-in-one blood sample collection and glucose analysis, closed a Series D financing. Participants include Venrock, Emergent Medical Partners, Investor Growth Capital, Thomas McNerney and Partners, U.S. Venture Partners and Versant Ventures.

Flexion Therapeutics (Woburn, MA) advances high value specialty drug candidates through clinically meaningful proof of concept and beyond, the company plans to announce deals with three major pharmas shortly, closed a $33M Series A financing. Participants include Versant Ventures, 5AM Ventures and Sofinnova Ventures. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

« Previous Page  Next Entries »

to top of page...